From the Department of Radiological Functions, Radiology Unit, Guglielmo da Saliceto Hospital, Via Taverna 49, 29121, Piacenza, Italy (D.C., F.C.B., M.P., G. Maffi, N.M., E.M.); and Department of Medicine and Surgery (DiMeC), University of Parma, Parma, Italy (G. Milanese, M.S., N.S.).
Radiology. 2020 Aug;296(2):E86-E96. doi: 10.1148/radiol.2020201433. Epub 2020 Apr 17.
Background CT of patients with severe acute respiratory syndrome coronavirus 2 disease depicts the extent of lung involvement in coronavirus disease 2019 (COVID-19) pneumonia. Purpose To determine the value of quantification of the well-aerated lung (WAL) obtained at admission chest CT to determine prognosis in patients with COVID-19 pneumonia. Materials and Methods Imaging of patients admitted at the emergency department between February 17 and March 10, 2020 who underwent chest CT were retrospectively analyzed. Patients with negative results of reverse-transcription polymerase chain reaction for severe acute respiratory syndrome coronavirus 2 at nasal-pharyngeal swabbing, negative chest CT findings, and incomplete clinical data were excluded. CT images were analyzed for quantification of WAL visually (%V-WAL), with open-source software (%S-WAL), and with absolute volume (VOL-WAL). Clinical parameters included patient characteristics, comorbidities, symptom type and duration, oxygen saturation, and laboratory values. Logistic regression was used to evaluate the relationship between clinical parameters and CT metrics versus patient outcome (intensive care unit [ICU] admission or death vs no ICU admission or death). The area under the receiver operating characteristic curve (AUC) was calculated to determine model performance. Results The study included 236 patients (59 of 123 [25%] were female; median age, 68 years). A %V-WAL less than 73% (odds ratio [OR], 5.4; 95% confidence interval [CI]: 2.7, 10.8; < .001), %S-WAL less than 71% (OR, 3.8; 95% CI: 1.9, 7.5; < .001), and VOL-WAL less than 2.9 L (OR, 2.6; 95% CI: 1.2, 5.8; < .01) were predictors of ICU admission or death. In comparison with clinical models containing only clinical parameters (AUC = 0.83), all three quantitative models showed better diagnostic performance (AUC = 0.86 for all models). The models containing %V-WAL less than 73% and VOL-WAL less than 2.9 L were superior in terms of performance as compared with the models containing only clinical parameters ( = .04 for both models). Conclusion In patients with confirmed coronavirus disease 2019 pneumonia, visual or software quantification of the extent of CT lung abnormality were predictors of intensive care unit admission or death. © RSNA, 2020
背景 :对严重急性呼吸综合征冠状病毒 2 型疾病患者的 CT 检查可描述 2019 年冠状病毒病(COVID-19)肺炎中肺受累的程度。目的 :确定入院时胸部 CT 检查中通气良好的肺(WAL)的定量值对 COVID-19 肺炎患者预后的预测价值。材料与方法 :对 2020 年 2 月 17 日至 3 月 10 日在急诊科入院并接受胸部 CT 检查的患者进行回顾性分析。排除鼻咽拭子 SARS-CoV-2 逆转录聚合酶链反应结果为阴性、胸部 CT 检查结果阴性以及临床资料不完整的患者。使用开源软件对 CT 图像进行 WAL 目测(%V-WAL)、定量(%S-WAL)和绝对体积(VOL-WAL)分析。临床参数包括患者特征、合并症、症状类型和持续时间、血氧饱和度和实验室值。采用 logistic 回归评估临床参数和 CT 指标与患者结局(入住重症监护病房[ICU]或死亡与未入住 ICU 或死亡)之间的关系。计算受试者工作特征曲线(ROC)下面积(AUC)以确定模型性能。结果 :本研究共纳入 236 例患者(123 例患者中 59 例[25%]为女性;中位年龄为 68 岁)。WAL 小于 73%(比值比[OR],5.4;95%置信区间[CI]:2.7,10.8;<.001)、WAL 小于 71%(OR,3.8;95% CI:1.9,7.5;<.001)和 VOL-WAL 小于 2.9 L(OR,2.6;95% CI:1.2,5.8;<.01)是入住 ICU 或死亡的预测因素。与仅包含临床参数的临床模型相比(AUC = 0.83),所有三种定量模型的诊断性能均更好(所有模型的 AUC = 0.86)。与仅包含临床参数的模型相比,包含 WAL 小于 73%和 VOL-WAL 小于 2.9 L 的模型的性能均更优(两个模型的 P 值均<.04)。结论 :在确诊为 2019 年冠状病毒病的患者中,CT 肺部异常程度的目测或软件定量是入住 ICU 或死亡的预测因素。© RSNA,2020